State of Wisconsin Investment Board
KPTI icon

State of Wisconsin Investment Board’s Karyopharm Therapeutics KPTI Stock Holding History

State of Wisconsin Investment Board’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,162
Closed -$768K – 2441
2023
Q1 		$768K Buy
13,162
+12,492
+1,864% +$617K ﹤0.01% 1619
2022
Q4 		$34.2K Sell
670
-3,979
-86% -$276K ﹤0.01% 2424
2022
Q3 		$381K Sell
4,649
-207
-4% -$15.5K ﹤0.01% 2103
2022
Q2 		$329K Sell
4,856
-1,531
-24% -$140K ﹤0.01% 2284
2022
Q1 		$706K Hold
6,387
– – ﹤0.01% 1719
2021
Q4 		$616K Buy
6,387
+27
+0.4% +$2.69K ﹤0.01% 1615
2021
Q3 		$555K Hold
6,360
– – ﹤0.01% 1666
2021
Q2 		$985K Hold
6,360
– – ﹤0.01% 1457
2021
Q1 		$1M Sell
6,360
-307
-5% -$64.7K ﹤0.01% 1367
2020
Q4 		$1.55M Sell
6,667
-2,313
-26% -$536K ﹤0.01% 1243
2020
Q3 		$1.97M Buy
8,980
+2,393
+36% +$585K ﹤0.01% 1163
2020
Q2 		$1.87M Buy
6,587
+460
+8% +$136K 0.01% 1137
2020
Q1 		$1.76M Buy
6,127
+354
+6% +$97.6K 0.01% 1084
2019
Q4 		$1.66M Hold
5,773
– – ﹤0.01% 1161
2019
Q3 		$833K Buy
5,773
+1,346
+30% +$182K ﹤0.01% 1180
2019
Q2 		$398K Buy
4,427
+100
+2% +$8.03K ﹤0.01% 1383
2019
Q1 		$379K Buy
4,327
+994
+30% +$110K ﹤0.01% 1400
2018
Q4 		$468K Buy
3,333
+40
+1% +$6.75K ﹤0.01% 1334
2018
Q3 		$841K Hold
3,293
– – ﹤0.01% 1265
2018
Q2 		$839K Buy
3,293
+1,560
+90% +$386K ﹤0.01% 1228
2018
Q1 		$349K Hold
1,733
– – ﹤0.01% 1350
2017
Q4 		$250K Hold
1,733
– – ﹤0.01% 1370
2017
Q3 		$285K Hold
1,733
– – ﹤0.01% 1375
2017
Q2 		$235K Buy
+1,733
New +$256K ﹤0.01% 1388

Other funds holding KPTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

State of Wisconsin Investment Board's KPTI Position: Q2 2023 in Review

State of Wisconsin Investment Board sold out of Karyopharm Therapeutics (KPTI) in Q2 2023, closing a stake of 13,162 shares — an estimated $768K sold.

State of Wisconsin Investment Board first reported a position in KPTI in Q2 2017 and held it in 24 quarters. The position peaked at $1.97M in Q3 2020. 137 funds tracked by Wall St. Rank hold KPTI as of Q2 2023.

  • State of Wisconsin Investment Board reported no remaining Karyopharm Therapeutics position as of Q2 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 13,162 Karyopharm Therapeutics shares in Q2 2023, an estimated $768K.
  • State of Wisconsin Investment Board first reported a position in Karyopharm Therapeutics in Q2 2017 and held it in 24 quarters.
  • State of Wisconsin Investment Board's Karyopharm Therapeutics position peaked at $1.97M in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2023, filed 14 Aug 2023.